Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Infection-related arthritis
•
General Rheumatology
•
Infectious Disease
•
Infection Prevention and Control
In patients taking biologics who are planning joint replacement and are known MRSA carriers do you perform decolonization prior to surgery?
Related Questions
What is the recommended fungal workup in an immunocompromised patient after 5 days of persistent fever?
Do you provide empiric doxycycline for Lyme Disease to asymptomatic patients after a tick bite who haven't developed Erythema migrans or are not sure it was an Ixodes tick?
Do you regularly recommend an immunological workup for patients with suspected immunodeficiency or defer to immunology?
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
Do you have to extend treatment for acute Lyme disease if a patient is on high dose steroids for another indication?
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
What are some situations where a non-prednisone steroid would be more appropriate than prednisone?
How do you approach a patient with high titer ANA and a new diagnosis of ITP, but no other signs or symptoms suggestive of active rheumatologic disease?
